The emergence of primary negative symptoms: relevance of timing?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 37184101.
- Also identified by DOI 10.1192/bjp.2023.51.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Negative symptoms are an important symptom dimension in schizophrenia that are often least responsive to antipsychotic medications. We revisit the current practice of identifying 'primary' negative symptoms and suggest that its concept would benefit from a further elaboration of their timing of emergence in relation to the dynamic neurobiological changes to enhance their utility in clinical decision-making and research.
Medical subject headings
- Schizophrenia
- Antipsychotic Agents